Polysaccharide-Based Nanomedicines Targeting Lung Cancer

Polysaccharide-Based Nanomedicines Targeting Lung Cancer

A primary illness that accounts for a significant portion of fatalities worldwide is cancer. Among the main malignancies, lung cancer is recognised as the most chronic kind of cancer around the globe. Radiation treatment, surgery, and chemotherapy are some medical procedures used in the traditional...

Full description

Bibliographic Details
Main Authors: Asif Ahmad Bhat, Gaurav Gupta, Khalid Saad Alharbi, Obaid Afzal, Abdulmalik S. A. Altamimi, Waleed Hassan Almalki, Imran Kazmi, Fahad A. Al-Abbasi, Sami I. Alzarea, Dinesh Kumar Chellappan, Sachin Kumar Singh, Ronan MacLoughlin, Brian G Oliver, Kamal Dua
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Pharmaceutics
Subjects:
lung cancer
polysaccharide
nanomedicines
immunity
chemotherapy
Online Access:https://www.mdpi.com/1999-4923/14/12/2788

Similar Items

Similar Items